News

Medifast’s first quarter results reflected ongoing headwinds in customer demand and a rapidly evolving health and wellness ...
We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core ...
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...
Over the four weeks, this full-body strength plan will teach you basic strength training moves to build your foundation. Then ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new information about its medically-guided weight management program. Designed ...
For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
1. Thinking in the short term Everything on this list is somewhat of a hard truth, but this is often the hardest to accept (and change). If you approach weight loss with a short-term attitude, you ...
Intermittent fasting resulted in similar weight loss as traditional calorie restriction, according to a new review. Experts say that the similar results across different diet protocols mean ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.